Twist Bioscience Corporation Long-Term Debt
Twist Bioscience Corporation (TWST) had Long-Term Debt of $625.00 thousand as of 2020-12-31, per its 10-Q filed 2021-02-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2021-11-23
- 2020-12-31: Long-term Debt, Excluding Current Maturities $625.00K.
- 2020-09-30: Long-term Debt, Excluding Current Maturities $1.40M.
- 2020-06-30: Long-term Debt, Excluding Current Maturities $2.17M.
- 2020-03-31: Long-term Debt, Excluding Current Maturities $2.92M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2020-12-31 | $625.00K 10-Q · filed 2021-02-09 |
| 2020-09-30 | $1.40M 10-K · filed 2021-11-23 |
| 2020-06-30 | $2.17M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $2.92M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $3.67M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $4.40M 10-K · filed 2020-11-27 |
| 2019-06-30 | $5.12M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $5.83M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $6.53M 10-Q · filed 2019-02-11 |
| 2018-09-30 | $7.22M 10-K · filed 2019-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |